ORIC Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update Portfolio News / By Karina Tin August 11, 2022
RAPT Therapeutics Reports Second Quarter 2022 Financial Results Portfolio News / By Karina Tin August 11, 2022
Surrozen Reports Second Quarter 2022 Financial Results Portfolio News / By Karina Tin August 11, 2022
Tenaya Therapeutics Reports Second Quarter 2022 Financial Results & Provides Business Update Portfolio News / By Karina Tin August 10, 2022
eFFECTOR Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update Portfolio News / By Karina Tin August 9, 2022
eFFECTOR Therapeutics Appoints Douglas Warner, M.D., as Chief Medical Officer Portfolio News / By Karina Tin August 8, 2022
Kallyope’s Newly Established Clinical Development Advisory Board Joined By Renowned Biopharma Leaders Portfolio News / By Karina Tin August 5, 2022
NGM Bio Provides Business Highlights and Reports Second Quarter 2022 Financial Results Portfolio News / By Karina Tin August 4, 2022
Nurix Therapeutics Announces Appointment of Eric Schlezinger, J.D. as Chief People Officer Portfolio News / By Karina Tin August 3, 2022